AKORN INC
10-Q, EX-27, 2000-08-14
PHARMACEUTICAL PREPARATIONS
Previous: AKORN INC, 10-Q, EX-11.1, 2000-08-14
Next: AMSOUTH BANCORPORATION, 10-Q, 2000-08-14



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION FROM CONSOLIDATED FINANCIAL
STATEMENTS FOR THE QUARTER ENDED JUNE 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY
BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                         425,768
<SECURITIES>                                         0
<RECEIVABLES>                               22,390,426
<ALLOWANCES>                                 (535,690)
<INVENTORY>                                 18,038,994
<CURRENT-ASSETS>                            42,279,524
<PP&E>                                      38,774,247
<DEPRECIATION>                            (12,578,308)
<TOTAL-ASSETS>                              88,636,022
<CURRENT-LIABILITIES>                        7,134,103
<BONDS>                                              0
                                0
                                          0
<COMMON>                                    21,435,150
<OTHER-SE>                                  18,975,652
<TOTAL-LIABILITY-AND-EQUITY>                88,636,022
<SALES>                                     34,964,584
<TOTAL-REVENUES>                            34,964,584
<CGS>                                       16,765,498
<TOTAL-COSTS>                               16,765,498
<OTHER-EXPENSES>                            10,698,180
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           1,144,123
<INCOME-PRETAX>                              6,441,825
<INCOME-TAX>                                 2,463,832
<INCOME-CONTINUING>                          3,977,993
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 3,977,993
<EPS-BASIC>                                        .21
<EPS-DILUTED>                                      .20


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission